OMIM Search - '+cs_neurologic:("developmental delay" OR "delayed development" OR "Delayed motor development" OR "Delayed psychomotor development" OR "Developmental motor delay" OR "Delayed walking development" OR "Delayed global development" OR "Global developmental delay" OR "Motor delay" OR "Fine motor impairment" OR "Psychomotor delay" OR "Delayed gross motor development" OR "Impaired psychomotor development" OR "Poor motor development" OR "Delay in gross motor development" OR "Lack of motor development" OR "Psychomotor retardation" OR "Lack of psychomotor development" OR "Developmental arrest" OR "Progressive psychomotor deterioration" OR "Developmental regression" OR "Psychomotor development failure" OR "Motor deterioration" OR "Motor retardation" OR "Retarded psychomotor development" OR "Delayed gross motor skills" OR "Arrest of psychomotor development" OR "Delay in motor development" OR "Delayed motor and speech development" OR "Limited gross motor development" OR "No psychomotor development" OR "Loss of motor functions" OR "Retarded motor development" OR "Motor development delayed" OR "Regression of psychomotor development" OR "Absence of development" OR "delayed early gross motor development" OR "absent psychomotor development" OR "Slowed development" OR "Poor fine motor skills" OR "Delayed motor skills" OR "Progressive motor function loss" OR "loss of motor skills" OR "Pervasive developmental disorder" OR "Motor and sensory neuropathy" OR "Delayed motor milestones" OR "Impaired fine motor skills" OR "Locomotor delay" OR "Psychomotor regression" OR "Motor deficits" OR "motor loss" OR "Loss of fine motor skills" OR "Psychomotor degeneration" OR "motor signs" OR "motor neuron" OR "motor skill delay" OR "Developmental retardation" OR "Motor impairment" OR "motor axonal neuropathy" OR "Loss of developmental skills" OR "Developmental deterioration" OR "Delayed developmental milestones" OR "Abnormal development" OR "Delayed early motor milestones" OR "Impaired motor control" OR "Motor regression" OR "Lack of neurologic development" OR "Motor abnormalities" OR "Defects in fine motor skills" OR "Impairment of gross and fine motor coordination" OR "motor incoordination" OR "Psychomotor impairment" OR "Lack of developmental progress" OR "Arrest of development" OR "Lack of development" OR "Lack of developmental progress" OR "Lack of developmental milestones" OR "Developmental disability" OR "Poor or absent global development" OR "Poor or lack of developmental progress" OR "Delayed gross motor milestones" OR "Neuromotor delay") (Search in: Prefixes: #, Chromosomes: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)'
Downloaded:	Nov 17, 2020
Copyright (c) 1966-2020 Johns Hopkins University OMIM, data are provided for research purposes only.

MIM Number	Title	Included Titles	Cytogenetic Location	Genomic Coordinates (From NCBI/GRCh38)	Entrez Gene ID
#618237	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15		6q16.1		
#618397	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39		5q13.3		
#618251	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31		3q13.33		
#615290	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2A, CHILDHOOD ONSET, AUTOSOMAL DOMINANT; SMALED2A		9q22.31		
#619042	SPINAL MUSCULAR ATROPHY, INFANTILE, JAMES TYPE; SMAJI		7p14.3		
#612079	ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES		7q32.1		
#617523	NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM		1q22		
#618356	NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD		1q32.1		
#271980	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; SSADHD		6p22.3		
#607694	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD7		10q22.3		
#613670	MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES		3p13		
#613280	HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1		1q41		
#617804	NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL		3p21.31		
#618049	PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2		10q25.3		
#618917	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; NEDLIB		4q32.1		
#609541	SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN		11q13.2		
#614959	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 14; DEE14		9q34.3		
#615119	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6; MC4DN6		10q24.2		
#607225	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP		2q33.1		
#616683	LEUKODYSTROPHY, HYPOMYELINATING, 12; HLD12		11q23.3		
#618973	NEURODEGENERATION, INFANTILE-ONSET, BIOTIN-RESPONSIVE; NERIB		2p23.3		
#617575	NEPHROTIC SYNDROME, TYPE 14; NPHS14		10q22.1		
#618239	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17		8q22.1		
#608716	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE; MCPH5		1q31.3		
#616471	BETHLEM MYOPATHY 2; BTHLM2		6q13-q14		
#618414	MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA		2q34		
#618707	NEURODEVELOPMENTAL DISORDER WITH ABSENT LANGUAGE AND VARIABLE SEIZURES; NEDALVS		6q21		
#618276	NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA		9q21.33		
#602522	BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4A	SENSORINEURAL DEAFNESS WITH MILD RENAL DYSFUNCTION, INCLUDED	1p32.3		
#613090	BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4B		1p36.13, 1p36.13		
#618228	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6		1q23.3		
#615578	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18; COXPD18		10q26.11		
#617831	MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55		6q22.1		
#617613	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5		9q21.33		
#614678	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B; PCH1B		9p13.2		
#214150	CEREBROOCULOFACIOSKELETAL SYNDROME 1; COFS1		10q11.23		
#253280	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3		1p34.1		
#617184	MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A		4q35.1		
#616505	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB, WITH OPTIC ATROPHY; HMSN6B		5q22.1		
#618241	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19		11q24.2		
#169500	LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD		5q23.2		
#251950	MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA		7q31.1		
#614696	AMYOTROPHIC LATERAL SCLEROSIS 17; ALS17		3p11.2		
#619004	DEEAH SYNDROME; DEEAH		11p11.2		
#610006	2-METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY		10q26.13		
#616007	CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS		1q41		
#618947	ARTHROGRYPOSIS MULTIPLEX CONGENITA 5; AMC5		9q34.11		
#618476	BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS		5q32		
#617668	ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA		11q13.4		
#618387	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3		1p32.3		
#615889	LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP		6p21.1		
#618412	GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG		2q32.2		
#619065	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21; MC4DN21		7p21.3		
#617914	MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20		1q32.1		
#619025	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 50; COXPD50		3p25.1		
#618891	MICROCEPHALY, DEVELOPMENTAL DELAY, AND BRITTLE HAIR SYNDROME; MDBH		11p15.4		
#205100	AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2		2q33.1		
#602433	AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4		9q34.13		
#606070	AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21		5q31.2		
#606353	PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ		2q33.1		
#614373	AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16		9p13.3		
#615515	AMYOTROPHIC LATERAL SCLEROSIS 19; ALS19		2q34		
#616208	AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS22		2q35		
#616437	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3		5q35.3		
#617839	AMYOTROPHIC LATERAL SCLEROSIS 23; ALS23		10q22.3		
#245348	PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD		11q23.1		
#611726	EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS; EPM3		7q11.21		
#610127	CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10	NEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	11p15.5		
#212140	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP		5q31.1		
#615282	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2		2q23.1-q23.2		
#617207	ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO		1q42.3		
#604484	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO		3q12.2		
#614877	PEROXISOME BIOGENESIS DISORDER 8B; PBD8B		11p11.2		
#143095	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS; SEDCJD		10q22.1		
#614504	USHER SYNDROME, TYPE IIIB; USH3B		5q31.3		
#614856	OSTEOGENESIS IMPERFECTA, TYPE XIII; OI13		8p21.3		
#615539	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2		6q22.1		
#617087	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B		1p36.22		
#617821	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2		7q21.3		
#618683	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6; MC5DN6		10q24.33		
#611943	RIDDLE SYNDROME; RIDL		3q29		
#614457	ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR		6q14.1		
#618006	LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17		7p22.1		
#616034	2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD		5p13.2		
#617820	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR		9q34.3		
#617822	ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS		4q27		
#230600	GM1-GANGLIOSIDOSIS, TYPE II	GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	3p22.3		
#616682	SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS		11p11.2		
#612289	FONTAINE PROGEROID SYNDROME; FPS		1p13.3		
#216550	COHEN SYNDROME; COH1		8q22.2		
#602083	USHER SYNDROME, TYPE IF; USH1F		10q21.1		
#603736	OHDO SYNDROME, SBBYS VARIANT; SBBYSS		10q22.2		
#225410	EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE; EDSDERMS		5q35.3		
#226960	LOWRY-WOOD SYNDROME; LWS		2q14.2		
#250400	METAPHYSEAL DYSPLASIA, SPAHR TYPE; MDST		11q22.2		
#609285	NEMALINE MYOPATHY 4; NEM4	CAP MYOPATHY 2, INCLUDED; CAPM2, INCLUDED	9p13.3		
#610542	MYASTHENIC SYNDROME, CONGENITAL, 12; CMS12		2p13.3		
#601536	ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS	BOSLEY-SALIH-ALORAINY SYNDROME, INCLUDED; BSAS, INCLUDED	7p15.2		
#612582	CHROMOSOME 6pter-p24 DELETION SYNDROME		6pter-p24		
#610532	LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5		7p15.3		
#610706	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA		11q13.3		
#614653	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6		6p12.1		
#250950	3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1		9q22.31		
#618484	ARTHROGRYPOSIS MULTIPLEX CONGENITA 3, MYOGENIC TYPE; AMC3		6q25.2		
#612989	OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7		11q14.1		
#613135	PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1		5p15.33		
#613224	NOONAN SYNDROME 6; NS6		1p13.2		
#615438	INFANTILE LIVER FAILURE SYNDROME 1; ILFS1		5q32		
#616728	CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES; CPRF		1p36.12		
#617053	MIRAGE SYNDROME; MIRAGE		7q21.2		
#617641	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED		1q23.3		
#618805	TRIOKINASE AND FMN CYCLASE DEFICIENCY SYNDROME; TKFCD		11q12.2		
#618856	DIABETES MELLITUS, PERMANENT NEONATAL 2; PNDM2	DEVELOPMENTAL DELAY, EPILEPSY, AND NEONATAL DIABETES 1, INCLUDED; DEND1, INCLUDED	11p15.1		
#619074	CLEFT PALATE, PROLIFERATIVE RETINOPATHY, AND DEVELOPMENTAL DELAY; CPPRDD		11q13.5		
#252930	MUCOPOLYSACCHARIDOSIS, TYPE IIIC; MPS3C		8p11.2-p11.1		
#268800	SANDHOFF DISEASE	SANDHOFF DISEASE, ADULT TYPE, INCLUDED	5q13.3		
#618230	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8		11p11.2		
#617787	MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50		4q31.1		
#105550	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 1; FTDALS1		9p21.2		
#601162	SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A		10q24.1		
#604320	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1		11q13.3		
#253300	SPINAL MUSCULAR ATROPHY, TYPE I; SMA1		5q13.2		
#253310	LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1		9q34.11		
#263570	POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM; APBN		3p12.2		
#607641	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB; HMN7B		2p13.1		
#612069	AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED, INCLUDED	1p36.22		
#611067	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4; DSMA4		1p36.31		
#613728	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10		3p22.1-p21.3		
#617892	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24		4q33		
#618193	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2; PLOSL2		6p21.1		
#613811	PONTOCEREBELLAR HYPOPLASIA, TYPE 2D; PCH2D		4p15.2		
#614498	RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL		7p22.3		
#614830	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8; MDDGA8		3p22.1		
#615042	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U		9q34.11		
#615287	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13		11q13.2		
#615476	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 18; DEE18		1p34.2		
#616342	LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7		7q36.1		
#617507	PEHO-LIKE SYNDROME; PEHOL		2p16.1		
#618011	HYPEREKPLEXIA 4; HKPX4		10q23.31		
#253800	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4		9q31.2		
#238700	HYPERLYSINEMIA, TYPE I		7q31.32		
#613002	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2		4q35.1		
#614932	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13		2p16.1		
#616239	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24		11q14.1		
#616981	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 37; DEE37		9q31.3		
#617105	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 41; DEE41		11p13		
#617171	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND IMPAIRED EXPRESSIVE LANGUAGE AND WITH OR WITHOUT SEIZURES; NEDHELS		11p15.5		
#617669	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS		2p25.3		
#618225	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4		11q13.2		
#618226	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5		2q33.3		
#618426	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9		9q34.13		
#618497	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH		9q34.3		
#618855	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 44; COXPD44		2q33.3		
#618873	LISSENCEPHALY 10; LIS10		6q22.31		
#618877	LEUKOENCEPHALOPATHY, DEVELOPMENTAL DELAY, AND EPISODIC NEUROLOGIC REGRESSION SYNDROME; LEUDEN		2p22.2		
#618916	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 87; DEE87		6q21		
#619026	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES; NEDSWMA		1p34.1		
#616155	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S		11q13.3		
#100800	ACHONDROPLASIA; ACH		4p16.3		
#117360	SPINOCEREBELLAR ATAXIA 29; SCA29		3p26.1		
#601596	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C		5q32		
#605253	NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL DOMINANT, INCLUDED	10q21.3		
#609060	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1		3q25.32		
#145900	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS		1q23.3, 10q21.3, 17p12, 19q13.2		
#156200	MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1	CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	2q23.1		
#161800	NEMALINE MYOPATHY 3; NEM3	MYOPATHY, ACTIN, CONGENITAL, WITH EXCESS OF THIN MYOFILAMENTS, INCLUDED	1q42.13		
#180800	ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA		1q23.3, 17p12		
#180860	SILVER-RUSSELL SYNDROME 1; SRS1		11p15.5		
#206700	GILLESPIE SYNDROME; GLSP		3p26.1		
#210000	BEHR SYNDROME; BEHRS		3q29		
#212350	SENGERS SYNDROME		7q34		
#214400	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A		8q21.11		
#601382	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1		11q21		
#602771	RIGID SPINE MUSCULAR DYSTROPHY 1; RSMD1		1p36.11		
#225400	EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1; EDSKSCL1		1p36.22		
#230740	GAPO SYNDROME; GAPOS		2p13.3		
#231000	GAUCHER DISEASE, TYPE III; GD3	GAUCHER DISEASE, TYPE IIIA, INCLUDED	1q22		
#233400	PERRAULT SYNDROME 1; PRLTS1		5q23.1		
#235730	MOWAT-WILSON SYNDROME; MOWS		2q22.3		
#239000	PAGET DISEASE OF BONE 5, JUVENILE-ONSET; PDB5		8q24.12		
#254940	CAREY-FINEMAN-ZITER SYNDROME; CFZS		9q34.2		
#255200	MYOPATHY, CENTRONUCLEAR, 2; CNM2		2q14.3		
#256030	NEMALINE MYOPATHY 2; NEM2		2q23.3		
#264070	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D; HPABH4D		10q22.1		
#274000	THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR		1q21.1		
#276900	USHER SYNDROME, TYPE I; USH1	USHER SYNDROME, TYPE IB, INCLUDED; USH1B, INCLUDED	11q13.5		
#606703	DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM		3q21.1		
#607317	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4		1p36.22-p36.21		
#607684	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E		8p21.2		
#607734	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F		8p21.2		
#608629	JOUBERT SYNDROME 3; JBTS3		6q23.3		
#608930	MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B		2q31.1		
#611890	CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD		9q34.11		
#612067	DYSTONIA 16; DYT16		2q31.2		
#612379	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq; CDG1Q		4q12		
#612656	EPISODIC ATAXIA, TYPE 6; EA6		5p13.2		
#612713	KAHRIZI SYNDROME; KHRZ		4q12		
#612937	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15		1q22		
#613151	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 3; MDDGB3		1p34.1		
#613157	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3		1p34.1		
#613162	SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45		10q24.32-q24.33		
#613205	MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED		1q22		
#613443	MENTAL RETARDATION, AUTOSOMAL DOMINANT 20; MRD20	CHROMOSOME 5q14.3 DELETION SYNDROME, PROXIMAL, INCLUDED	5q14.3		
#609284	NEMALINE MYOPATHY 1; NEM1	CAP MYOPATHY 1, INCLUDED; CAPM1, INCLUDED	1q21.3		
#609308	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1		9q34.13		
#610031	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7; CDCBM7		6p25.2		
#610357	SPASTIC PARAPLEGIA 30, AUTOSOMAL DOMINANT; SPG30	SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE, INCLUDED	2q37.3		
#611105	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL		1q25.1		
#611228	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J; CMT4J		6q21		
#613723	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 17; LGMDR17		8q24.3		
#613925	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A		11q24.2		
#613926	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B		11q24.2		
#614069	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2; ICF2		6q21		
#614399	MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET; EMARDD	MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET, MILD VARIANT, INCLUDED	5q23.2		
#614557	EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2		7p14.3		
#614619	HYPEREKPLEXIA 2; HKPX2		4q32.1		
#614750	MYASTHENIC SYNDROME, CONGENITAL, 13; CMS13		11q23.3		
#615030	SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56		4q25		
#615219	HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2		9p23		
#615281	HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY; HBSL		2q21.3		
#615352	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14		3p21.31		
#615548	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7		3p22.2		
#615673	MYOPATHY WITH EXTRAPYRAMIDAL SIGNS; MPXPS		10q22.1		
#615705	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15		3q29		
#615731	NEMALINE MYOPATHY 9; NEM9		2q31.1		
#615959	MYOPATHY, CENTRONUCLEAR, 5; CNM5		2q35		
#616033	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1		4q23		
#616094	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12		8p11.21		
#616224	MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22		2p21		
#616228	MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14		9q22.33		
#616291	LICHTENSTEIN-KNORR SYNDROME; LIKNS		1p36.11		
#616321	MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A		2q37.1		
#616322	MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B		2q37.1		
#616323	MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C		2q37.1		
#616326	MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11		11p11.2		
#616489	SILVER-RUSSELL SYNDROME 3; SRS3		11p15.5		
#616719	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21; SCAR21		11q13.1		
#616720	MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19		10q22.1		
#616739	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51; MRT51		2q22.1		
#616921	DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD		6q27		
#617061	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 44, WITH MICROCEPHALY; MRD44		5p15.2		
#617282	DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG		1p35.3		
#617412	BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD		5q14.2		
#617560	SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8		10q26.3		
#617675	MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT		1q22		
#617691	SPINOCEREBELLAR ATAXIA 44; SCA44		6q24.3		
#617760	MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6		2q31.1		
#617763	SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF		9q34.12		
#617882	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG		8p21.2		
#617915	HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS		4p16.3		
#617931	SPINOCEREBELLAR ATAXIA 47; SCA47		1p35.2		
#618135	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8		3p22.1		
#618138	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23		6q22.33		
#618184	NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2		1q23.3		
#618291	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B		9q22.31		
#618343	POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV		2q32.2		
#618381	FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG		11q13.1		
#618578	MYOPATHY, CONGENITAL, PROGRESSIVE, WITH SCOLIOSIS; MYOSCO		1p36.13		
#618688	LEUKODYSTROPHY, HYPOMYELINATING, 19, TRANSIENT INFANTILE; HLD19		1q42.12		
#618768	SPASTIC PARAPLEGIA 81, AUTOSOMAL RECESSIVE; SPG81		2p23.3		
#618800	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 28; SCAR28		5q33.3		
#618823	MYOPATHY, CONGENITAL PROXIMAL, WITH MINICORE LESIONS; MYOPMIL		3q26.33		
#618975	MYOPATHY, CONGENITAL, WITH DIAPHRAGMATIC DEFECTS, RESPIRATORY INSUFFICIENCY, AND DYSMORPHIC FACIES; MYODRIF		11p15.1		
#618992	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 15; MDDGB15		1q22		
#614702	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10; COXPD10		6q13		
#615362	CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13		11q13.2		
#617248	3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8		2p13.1		
#618379	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73		3q25.1		
#618835	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40; COXPD40		6q21		
#126550	CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY AND SPONDYLOMETAPHYSEAL DYSPLASIA, INCLUDED; CDLSMD, INCLUDED	4q25		
#156610	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1		6p21.33		
#213980	CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME; CFSMR		1q24.1		
#242900	SCHIMKE IMMUNOOSSEOUS DYSPLASIA; SIOD		2q35		
#245600	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS; JDSCD		11q12.3		
#249420	FRANK-TER HAAR SYNDROME; FTHS		5q35.1		
#263520	SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6		4q33		
#605407	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE		11p15.5		
#609583	JOUBERT SYNDROME 4; JBTS4		2q13		
#616507	OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17		5q33.1		
#616835	MEIER-GORLIN SYNDROME 6; MGORS6		6p22.3		
#616943	TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6		8p12		
#617026	PONTOCEREBELLAR HYPOPLASIA, TYPE 2F; PCH2F		1q25.3		
#617164	SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD		11q23.3		
#617403	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D		3q13.31		
#617425	IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA		8p21.1		
#617917	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8		9q34.11		
#618188	HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN		7q34		
#618280	CARDIAC-UROGENITAL SYNDROME; CUGS		11q12.2		
#618804	SANDESTIG-STEFANOVA SYNDROME; SANDSTEF		9q34.11		
#618846	DIETS-JONGMANS SYNDROME; DIJOS		5q31.2		
#618853	ANAUXETIC DYSPLASIA 3; ANXD3		3q13.2		
#618870	SKELETAL DYSPLASIA, MILD, WITH JOINT LAXITY AND ADVANCED BONE AGE; SDJLABA		8p21.3		
#618914	NEURODEVELOPMENTAL, JAW, EYE, AND DIGITAL SYNDROME; NEDJED		5q35.1		
#228000	FARBER LIPOGRANULOMATOSIS; FRBRL		8p22		
#274270	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	5-FLUOROURACIL TOXICITY, INCLUDED	1p21.3		
#608233	HERMANSKY-PUDLAK SYNDROME 2; HPS2		5q14.1		
#608611	RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD		2p11.2		
#272750	GM2-GANGLIOSIDOSIS, AB VARIANT		5q33.1		
#612621	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5; MRD5		6p21.32		
#615846	AICARDI-GOUTIERES SYNDROME 7; AGS7		2q24.2		
#617153	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 45; DEE45		4p12		
#619057	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 51; COXPD51		2p11.2		
#609056	SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS		2p11.2		
#250620	3-HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY; HIBCHD		2q32.2		
#607208	DRAVET SYNDROME; DRVT		2q24.3		
#615744	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 19; DEE19		5q34		
#615838	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8		5q23.3-q31.1		
#616271	3-METHYLGLUTACONIC ACIDURIA, TYPE VII; MGCA7		11q13.4		
#616457	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 50; DEE50		2p23.3		
#616809	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6; HPMRS6		4q22.1		
#616900	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3		4q24		
#617166	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 47; DEE47		3q28-q29		
#617435	LOPES-MACIEL-RODAN SYNDROME; LOMARS		4p16.3		
#617711	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1		4q24		
#617771	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57		1q31.3		
#617951	LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15		1q41		
#617954	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6		7q22.1		
#618004	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64		8p21.3		
#213000	CEREBELLAR HYPOPLASIA/ATROPHY, EPILEPSY, AND GLOBAL DEVELOPMENTAL DELAY; CHEGDD		8q23.1		
#602342	PIERPONT SYNDROME; PRPTS		3q26.32		
#260600	LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3		4q24		
#606053	INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS		2q24.2		
#607872	CHROMOSOME 1p36 DELETION SYNDROME		1p36		
#613612	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I		7q22.3		
#613721	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 11; DEE11		2q24.3		
#613735	BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	CHROMOSOME 1p32-p31 DELETION SYNDROME, INCLUDED	1p31.3		
#613886	OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD		9q21.33		
#614075	HERMANSKY-PUDLAK SYNDROME 6; HPS6		10q24.32		
#614225	WARBURG MICRO SYNDROME 2; WARBM2		1q41		
#614226	HOLOPROSENCEPHALY 11; HPE11		11q24.2		
#614300	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY		10q22.2		
#614402	MICROPHTHALMIA, SYNDROMIC 11; MCOPS11		10q25.3		
#614615	JOUBERT SYNDROME 17; JBTS17		5p13.2		
#614883	PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER); PBD11A	PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 13, INCLUDED; CG13, INCLUDED	2p15		
#614886	PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER); PBD12A	PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 14, INCLUDED	1q23.2		
#614946	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14		6p25.1		
#615145	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	MICROPHTHALMIA, SYNDROMIC 15, INCLUDED; MCOPS15, INCLUDED	4q34.3-q35.1		
#615273	CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG		3p24.2		
#615471	MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13		6q16.1-q16.2		
#615474	PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES; PASNA		3p21.1		
#615763	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5		6p25.2		
#615789	SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF		2p21		
#615807	SECKEL SYNDROME 8; SCKL8		10q21.3		
#615948	OROFACIODIGITAL SYNDROME XIV; OFD14		11q13.4		
#616083	MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30		10p15.3		
#616351	MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34		5q13.3		
#616801	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2		2q34		
#616867	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2; SMABF2		10q22.1		
#616887	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52; MRT52		2q11.2		
#616939	CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION; COCPMR		1p21.2		
#616973	MENTAL RETARDATION, AUTOSOMAL DOMINANT 42; MRD42		1p36.33		
#616975	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH		1p36.23		
#617008	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3		10q25.1-q25.2		
#617020	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 38; DEE38		1q42.2		
#617051	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55; MRT55		11q24.2		
#617052	BONE MARROW FAILURE SYNDROME 3; BMFS3		5p13.2		
#617055	PERCHING SYNDROME; PERCHING		7p15.3		
#617281	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 49; DEE49		11p15.4		
#617302	OPTIC ATROPHY 11; OPA11		10p12.1		
#617330	HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS		10q26.3		
#617333	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP		3p25.3		
#617360	CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD		7p14.1		
#617481	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA		1q21.3		
#617527	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA		9p21.2		
#617616	SKRABAN-DEARDORFF SYNDROME; SKDEAS		1q42.11-q42.12		
#617746	SWEENEY-COX SYNDROME; SWCOS		7p21.1		
#617773	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61		9p13.3		
#617816	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16		1q24.3		
#617836	DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM		1p36.11		
#617864	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA		11q22.3		
#617865	NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA		5q12.1		
#617873	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35		1p34.2		
#617938	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62		2q24.3		
#617991	CHUNG-JANSEN SYNDROME; CHUJANS		6q14.1		
#618027	COFFIN-SIRIS SYNDROME 7; CSS7		11q13.1		
#618158	INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD		11q13.5-q14.1		
#618174	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9		2p12		
#618222	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2		11q13.2		
#618233	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10		5q12.1		
#618235	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13		5q31.3		
#618240	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18		3p21.31		
#618246	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25		2q33.1		
#618292	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA		3p21.2		
#618298	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70		6p24.1		
#618314	HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2		1p13.1		
#618325	LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9		1p34.3		
#618330	GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI		7q22.1		
#618349	GALLOWAY-MOWAT SYNDROME 8; GAMOS8		1q42.13		
#618351	MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25		7q22.1		
#618354	NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA		5q31.1		
#618378	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38		1q25.1		
#618396	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74		5q34		
#618404	LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18		1q42.11		
#618425	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM		2q35		
#618437	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75		1p32.3		
#618453	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA		7p22.1		
#618454	DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA		7q22.1		
#618460	KHAN-KHAN-KATSANIS SYNDROME; 3KS		7q36.3		
#618470	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD		7q22.1		
#618492	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA		2q31.1		
#618493	HYPOTONIA, HYPOVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA		3p21.31		
#618501	CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD		3p21.31		
#618504	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71		11q22.3		
#618512	O'DONNELL-LURIA-RODAN SYNDROME; ODLURO		7q22.3		
#618522	INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59		10q22.2		
#618547	NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES; NEDVIBA		10q22.1		
#618557	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 78; EIEE78		4p12		
#618569	NEURODEVELOPMENTAL DISORDER WITH ATAXIA, HYPOTONIA, AND MICROCEPHALY; NEDAHM		1p34.2		
#618571	NEURODEVELOPMENTAL DISORDER WITH CATARACTS, POOR GROWTH, AND DYSMORPHIC FACIES; NDCAGF		7p22.3		
#618572	NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR HYPOPLASIA AND SPASTICITY; NEDCHS		8q22.1		
#618587	INTELLECTUAL DEVELOPMENTAL DISORDER 60 WITH SEIZURES; MRD60		3q27.1		
#618604	SNIJDERS BLOK-FISHER SYNDROME; SNIBFIS		2q12.1		
#618606	PONTOCEREBELLAR HYPOPLASIA, TYPE 13; PCH13		11q13.1		
#618619	WEISS-KRUSZKA SYNDROME; WSKA		9q31.2		
#618622	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES; NEDMABA		2q21.1		
#618646	DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 2; DMJDS2		4q12		
#618653	INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND DYSMORPHIC FACIES; IDDILF		11q23.3		
#618659	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL SKELETAL ANOMALIES; NEDDFSA		10q22.3		
#618665	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 72; MRT72		2q31.1		
#618687	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES; IDDSSBA		3p25.2-p25.1		
#618718	NEURODEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES, ABSENT SPEECH, AND HYPOTONIA; NEDBASH		9q34.13		
#618724	HEYN-SPROUL-JACKSON SYNDROME; HESJAS		2p23.3		
#618729	LIANG-WANG SYNDROME; LIWAS		10q22.3		
#618730	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CORTICAL MALFORMATIONS, AND SPASTICITY; NEDMCMS		11q12.1		
#618732	POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS		6p21.33		
#618737	PACHYGYRIA, MICROCEPHALY, DEVELOPMENTAL DELAY, AND DYSMORPHIC FACIES, WITH OR WITHOUT SEIZURES; PAMDDFS		10q26.3		
#618761	CATIFA SYNDROME; CATIFA		9p24.1		
#618763	JOUBERT SYNDROME 36; JBTS36		10q22.2		
#618792	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 84; DEE84		4p14		
#618798	BECK-FAHRNER SYNDROME; BEFAHRS		2p13.1		
#618808	INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA; IDPOGSA		9q34.3		
#618825	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY; MRD63		5p15.2		
#618872	NIZON-ISIDOR SYNDROME; NIZIDS		3q25.1		
#618879	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND CEREBELLAR ATROPHY, WITH OR WITHOUT SEIZURES; NEDHCAS		1p31.1		
#618885	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIt; CDG2T		1q42.13		
#618890	NEURODEVELOPMENTAL DISORDER AND STRUCTURAL BRAIN ANOMALIES WITH OR WITHOUT SEIZURES AND SPASTICITY; NEDBASS		3p21.31		
#618910	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 86; DEE86		3p21.31		
#618918	PERIVENTRICULAR NODULAR HETEROTOPIA 9; PVNH9		5q13.2		
#618922	NEURODEVELOPMENTAL DISORDER WITH SEIZURES, HYPOTONIA, AND BRAIN IMAGING ABNORMALITIES; NEDSHBA		3p26.1		
#618958	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 47; COXPD47		8q21.13		
#618959	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 88; DEE88		2p15		
#619005	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, IMPAIRED SPEECH, AND HYPOTONIA; NEDDISH		11p11.2		
#619059	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15; MC4DN15		11q13.1		
#618252	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32		10q24.31		
#617065	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 40; DEE40		4p12		
#249900	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY		10q22.1		
#252010	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1		5q11.2		
#614113	MENTAL RETARDATION, AUTOSOMAL DOMINANT 2; MRD2		9p24		
#615828	VULTO-VAN SILFHOUT-DE VRIES SYNDROME; VSVS		11p15.5		
#617013	HYPERMANGANESEMIA WITH DYSTONIA 2; HMNDYT2		8p21.3		
#618875	SEIZURES, EARLY-ONSET, WITH NEURODEGENERATION AND BRAIN CALCIFICATIONS; SENEBAC		3q29		
#614739	3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL		6q25.3		
#617132	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 44; DEE44		3q22.1		
#616276	COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7		9q34.11		
#614299	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2		2p13.1		
#615010	AICARDI-GOUTIERES SYNDROME 6; AGS6		1q21.3		
#616346	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 31; DEE31		9q34.11		
#614969	PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7		1p34.1		
#607417	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2		3p26.2		
#616651	ROIFMAN SYNDROME; RFMN		2q14.2		
#614052	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2		8q21.11		
#615249	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12		8p11.21		
#618339	INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID		2q32.2		
#245349	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY; PDHXD		11p13		
#608643	AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY		7p12.2-p12.1		
#612389	PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B		3p25.2		
#220111	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 5; MC4DN5		2p21		
#210200	3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D		3q27.1		
#210210	3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D		5q13.2		
#601539	PEROXISOME BIOGENESIS DISORDER 1B; PBD1B		7q21.2		
#266150	PYRUVATE CARBOXYLASE DEFICIENCY		11q13.2		
#261630	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C		4p15.32		
#261640	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, DUE TO PARTIAL PTS DEFICIENCY, INCLUDED	11q23.1		
#618741	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, SPASTICITY, AND BRAIN ATROPHY; NEDESBA		11q23.3		
#256730	CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1	NEURONAL CEROID LIPOFUSCINOSIS, INFANTILE, INCLUDED; INCL, INCLUDED	1p34.2		
#617982	VERVERI-BRADY SYNDROME; VERBRAS		3p21.31		
#252011	MITOCHONDRIAL COMPLEX II DEFICIENCY		5p15.33, 11q23.1, 19q13.12		
#615924	ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD		11q12.3		
#617186	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1		1q22		
#220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 1; MC4DN1		9q34.2		
#204500	CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2	NEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, INCLUDED; LINCL, INCLUDED	11p15.4		
#600143	CEROID LIPOFUSCINOSIS, NEURONAL, 8; CLN8		8p23.3		
#603896	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	VANISHING WHITE MATTER LEUKODYSTROPHY WITH OVARIAN FAILURE, INCLUDED	1p34.1, 2p23.3, 3q27.1, 12q24.31, 14q24.3		
#612164	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 4; DEE4		9q34.11		
#613068	NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY		11q13.4		
#614325	PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2		2p16.3		
#615330	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3		1q42.13		
#617595	BIRK-LANDAU-PEREZ SYNDROME; BILAPES		4p13		
#617762	LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO		11q13.5		
#617903	NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS		9q22.33		
#618170	NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS		1p34.3		
#618285	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69		1q25.3		
#124000	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1; MC3DN1		2q35		
#220120	D-GLYCERIC ACIDURIA		3p21.2		
#220210	RITSCHER-SCHINZEL SYNDROME 1; RTSC1		8q24.13		
#135900	COFFIN-SIRIS SYNDROME 1; CSS1		6q25.3		
#158170	CHROMOSOME 9p DELETION SYNDROME		9p		
#204750	2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD		10p14		
#213200	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2		9q34.3		
#213300	JOUBERT SYNDROME 1; JBTS1		9q34.3		
#216360	COACH SYNDROME		4p15.32, 8q22.1, 16q12.2		
#218040	COSTELLO SYNDROME; CSTLO	MYOPATHY, CONGENITAL, WITH EXCESS OF MUSCLE SPINDLES, INCLUDED; CMEMS, INCLUDED	11p15.5		
#600224	SPINOCEREBELLAR ATAXIA 5; SCA5		11q13.2		
#602398	DESMOSTEROLOSIS		1p32.3		
#603552	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4; FHL4		6q24.2		
#603553	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2; FHL2		10q22.1		
#603585	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F		6q15		
#605130	WIEDEMANN-STEINER SYNDROME; WDSTS		11q23.3		
#236270	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE; HMAE		5p15.31		
#245400	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA); MTDPS9		2p11.2		
#246900	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY; DLDD		7q31.1		
#248000	MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE; MGCPH		6p24.1		
#250940	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG COMPLEMENTATION TYPE; HMAG		1q43		
#251280	DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 1; DMJDS1		5q31.3		
#252150	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA		6p21.2		
#252160	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB		5q11.2		
#261515	D-BIFUNCTIONAL PROTEIN DEFICIENCY		5q23.1		
#264090	WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS		10q22.3		
#266100	EPILEPSY, PYRIDOXINE-DEPENDENT; EPD		5q23.2		
#272200	MULTIPLE SULFATASE DEFICIENCY; MSD		3p26.1		
#606056	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb; CDG2B		2p13.1		
#607454	SPINOCEREBELLAR ATAXIA 21; SCA21		1p36.33		
#607906	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I		9q22.33		
#608091	JOUBERT SYNDROME 2; JBTS2		11q12.2		
#608776	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L		11q23.1		
#608804	LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2		1q42.13		
#608885	STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN		1p34.2		
#609015	MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	TRIFUNCTIONAL PROTEIN DEFICIENCY WITH MYOPATHY AND NEUROPATHY, INCLUDED	2p23.3, 2p23.3		
#611816	TEMPLE-BARAITSER SYNDROME; TMBTS		1q32.2		
#612015	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In; CDG1N		3p21.1		
#612126	GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2		1p34.2		
#612313	GLASS SYNDROME; GLASS		2q33.1		
#612337	MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	CHROMOSOME 1q43-q44 DELETION SYNDROME, INCLUDED	1q44		
#612513	CHROMOSOME 2p16.1-p15 DELETION SYNDROME		2p16.1-p15	2:54700000-63900000	
#612716	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY		2p13.2		
#612936	SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50		7q22.1		
#612949	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 39; DEE39		2q31.1		
#612951	LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY		6q27		
#613155	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL IMPAIRMENT), TYPE B, 1; MDDGB1		9q34.13		
#613563	NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA; NSLL		11q23.3		
#609313	MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA; MEDNIK		7q22.1		
#609460	GOLDBERG-SHPRINTZEN SYNDROME; GOSHS		10q22.1		
#610042	PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1		7q35-q36		
#610329	AICARDI-GOUTIERES SYNDROME 3; AGS3		11q13.1		
#610759	CORNELIA DE LANGE SYNDROME 3 WITH OR WITHOUT MIDLINE BRAIN DEFECTS; CDLS3		10q25.2		
#610829	HOLOPROSENCEPHALY 9; HPE9		2q14.2		
#610951	CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7		4q28.2		
#611091	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5; MRT5		5p15.31		
#613603	CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME		4q32.1-q32.2	4:154600000-163600000	
#613647	SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48		7p22.1		
#613671	MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS		6q21		
#613818	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9		3p21.31		
#613839	MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY		5q14.1		
#614066	SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47		1p13.2		
#614115	CORTICAL MALFORMATIONS, OCCIPITAL; OCCM		9q34.12		
#614202	RAFIQ SYNDROME; RAFQS		9q34.3		
#614207	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3		11p15.4		
#614213	NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C		2q37.3		
#614254	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD		9q34.3		
#614255	NESCAV SYNDROME; NESCAVS		2q37.3		
#614261	MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME; MICCAP		2p13.1		
#614424	JOUBERT SYNDROME 14; JBTS14		2q33.1		
#614458	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE); THMD5		7q35		
#614464	JOUBERT SYNDROME 15; JBTS15	JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	7q32.2		
#614501	PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM; PMRED		1p34.3		
#614507	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir; CDG1R		1p36.12		
#614582	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9		3q22.1		
#614607	COFFIN-SIRIS SYNDROME 2; CSS2	CHROMOSOME 1p36.11 DUPLICATION SYNDROME, INCLUDED	1p36.11		
#614613	ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS2		5q11.2-q12.1		
#614727	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk; CDG2K		4q12		
#614741	MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY; MPYCD		6q27		
#614749	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2		9p13.3		
#614756	CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR		1p36.31-p36.23		
#614831	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13; SCAR13		6q24.3		
#614898	SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE; SPG53		8p22		
#614922	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11		6q25.1		
#615006	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 15; DEE15		1p34.1		
#615009	SCHUURS-HOEIJMAKERS SYNDROME; SHMS		11q13.1-q13.2		
#615033	SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54		8p11.23		
#615071	ALAZAMI SYNDROME; ALAZS		4q25		
#615074	GAND SYNDROME; GAND		1q21.3		
#615075	NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV		3p22.1		
#615159	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4		5q31.1		
#615181	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11		1q42.3		
#615285	NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5		1q21.2		
#615350	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14		3p21.31		
#615351	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 14; MDDGB14		3p21.31		
#615356	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18		4q35.1		
#615386	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14; SCAR14		11q13.2		
#615411	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3		5q12.1		
#615510	ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME; AAMR		2q35		
#615541	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39		8p12		
#615544	PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6		6q27		
#615553	ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES; AMRS		1p21.2		
#615574	ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD		7q21.3		
#615583	VERHEIJ SYNDROME; VRJS		8q24.3		
#615596	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W		11q24.2		
#615597	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X		3p23		
#615599	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40		8q24.12		
#615636	JOUBERT SYNDROME 21; JBTS21		8q13.1-q13.2		
#615665	JOUBERT SYNDROME 22; JBTS22		2q37.1		
#615668	CHROMOSOME 5q12 DELETION SYNDROME		5q12	5:59600000-67400000	
#615760	MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY; MSCCA		3p21.31		
#615761	MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23		3p25.3		
#615771	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6		6p21.33		
#615802	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42		2q33.1		
#615803	PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10		11q12.1		
#615809	PONTOCEREBELLAR HYPOPLASIA, TYPE 9; PCH9		1p13.3		
#615824	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7		6p21.31		
#615829	XIA-GIBBS SYNDROME; XIGIS		1p36.1-p35.3		
#615834	MENTAL RETARDATION, AUTOSOMAL DOMINANT 26; MRD26		7q11.22		
#615849	CULLER-JONES SYNDROME; CJS		2q14.2		
#615859	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 23; DEE23		1p31.3		
#615917	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20; COXPD20		6p21.33		
#615918	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21; COXPD21		1q21.2		
#615966	IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26		8q11.21		
#616051	MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13		4q24		
#616084	SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD		3p26.2		
#616111	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9; MC3DN9		11q12.3		
#616116	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46; MRT46		5q33.1		
#616127	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17		10q24.31		
#616140	LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9		5q34		
#616154	PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD		11p15.3		
#616158	MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31		5q31.3		
#616171	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2		4q28.1		
#616193	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47; MRT47		1q43		
#616204	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18		4q22.1-q22.2		
#616268	ARBOLEDA-THAM SYNDROME; ARTHS		8p11.21		
#616269	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48		1p13.3		
#616277	MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D		10q26.3		
#616299	LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D		2q11.2		
#616354	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20		6q14.3		
#616355	MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35		6p21.1		
#616364	WHITE-SUTTON SYNDROME; WHSUS		1q21.3		
#616368	CHOPS SYNDROME; CHOPS		5q31.1		
#616402	MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14		1p21.2		
#616418	HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 1; HOMGSMR1		10q24.32		
#616420	LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10		1q42.12		
#616430	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25		2q33.1		
#616459	AL-RAQAD SYNDROME; ARS		11q24.2		
#616486	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN IMAGING ABNORMALITIES; NEDMISBA		1p34.2		
#616494	LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11		6p21.1		
#616538	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9		3p21.31		
#616580	AU-KLINE SYNDROME; AUKS		9q21.32		
#616586	SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B		10q24.1		
#616632	SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME; SCBMS		5q31.3		
#616657	SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM		2p14		
#616708	DESANTO-SHINAWI SYNDROME; DESSH	CHROMOSOME 10p12-p11 DELETION SYNDROME, INCLUDED	10p12.1		
#616721	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn; CDG2N		4q24		
#616737	TAKENOUCHI-KOSAKI SYNDROME; TKS		1p36.12		
#616756	SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES; SPPRS		6q16.3		
#616781	JOUBERT SYNDROME 25; JBTS25		1p36.32		
#616816	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR		3p25.1		
#616819	CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA		10p13		
#616828	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo; CDG2O		2q21.1		
#616881	LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13		11q14.2		
#616896	MITOCHONDRIAL DNA DEPLETION SYNDROME 14 (CARDIOENCEPHALOMYOPATHIC TYPE); MTDPS14		3q29		
#616910	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3		2q31.1		
#616911	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4		10q23.33		
#616917	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53		4p16.3		
#616944	MENTAL RETARDATION, AUTOSOMAL DOMINANT 41; MRD41		3q26.32		
#616977	MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43		6q24.2		
#617082	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa; CDG1AA		6q22.1		
#617086	ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2; EMPF2		2q36.3		
#617093	GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH		9q22.31		
#617101	INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN		2p16.1		
#617107	THAUVIN-ROBINET-FAIVRE SYNDROME; TROFAS		11q13.1		
#617126	ALAZAMI-YUAN SYNDROME; ALYUS		7q22.1		
#617183	HAREL-YOON SYNDROME; HAYOS		1p36.33		
#617190	SHASHI-PENA SYNDROME; SHAPNS		2p23.3		
#617260	GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF		3q21.2		
#617268	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL		2q32.3		
#617290	EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D		8p11.23		
#617296	SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO		2p25.1		
#617301	GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE		1p34.1		
#617339	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 51; DEE51		7q11.23		
#617370	PEROXISOME BIOGENESIS DISORDER 10B; PBD10B		6q24.2		
#617384	HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4		10q21.3		
#617391	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 54; DEE54		1q44		
#617395	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q		1q42.2		
#617432	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60; MRT60		1p13.3		
#617452	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES; IDDFSDA		8q21.3		
#617561	COHEN-GIBSON SYNDROME; COGIS		11q14.2		
#617584	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25		6q21		
#617601	MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46		6q13		
#617622	JOUBERT SYNDROME 30; JBTS30		2q37.1		
#617635	MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47		3q22.3		
#617643	CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS		10q22.3		
#617660	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1		2p21		
#617665	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 56; DEE56		7q11.23		
#617695	PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11		3q12.1-q12.2		
#617709	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS		1p13.3		
#617710	NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS		1p12		
#617731	GALLOWAY-MOWAT SYNDROME 5; GAMOS5		2p13.1		
#617751	MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48		7p22.1		
#617752	CLARK-BARAITSER SYNDROME; CLABARS		2q36.3		
#617768	KLEEFSTRA SYNDROME 2; KLEFS2		7q36.1		
#617798	MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53		5q32		
#617799	MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54		7p13		
#617802	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA		6p21.33		
#617810	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15		8q24.3		
#617829	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2		5q34		
#617830	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 58; DEE58		9q21.33		
#617929	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60		6p21.1		
#617930	CHROMOSOME 1p35 DELETION SYNDROME		1p35	1:27600000-34300000	
#617935	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4		2q24.3		
#617950	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36		9q34.3		
#617976	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63		4p16.3		
#617988	JABERI-ELAHI SYNDROME; JABELS		6p21.1		
#618012	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3		3q13.31		
#618056	NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS		7p22.3		
#618065	PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D		4q27		
#618076	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG		1q23.3		
#618089	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA		2p16.3		
#618090	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC		2q31.1		
#618095	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63		5q32		
#618106	MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58		9q34.11		
#618109	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65		1q32.1		
#618185	PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8		1q42.13		
#158350	COWDEN SYNDROME 1; CWS1	LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED	10q23.31		
#206900	MICROPHTHALMIA, SYNDROMIC 3; MCOPS3	OPTIC NERVE HYPOPLASIA AND ABNORMALITIES OF THE CENTRAL NERVOUS SYSTEM, INCLUDED	3q26.33		
#601707	CURRY-JONES SYNDROME; CRJS		7q32.1		
#612233	LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4		2q33.1		
#612291	JOUBERT SYNDROME 8; JBTS8		3q11.1-q11.2		
#612780	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE; SESAMES		1q23.2		
#613544	CHROMOSOME 6q11-q14 DELETION SYNDROME	CHROMOSOME 6q13-q14 DELETION SYNDROME, INCLUDED	6q11-q14	6:59800000-87300000	
#614813	SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS; SOFT		3p21.2		
#618624	NOONAN SYNDROME 12; NS12		11p15.2		
#100300	ADAMS-OLIVER SYNDROME 1; AOS1	APLASIA CUTIS CONGENITA, CONGENITAL HEART DEFECT, AND FRONTONASAL CYSTS, INCLUDED	3q13.32-q13.33		
#115150	CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1		7q34		
#117550	SOTOS SYNDROME 1; SOTOS1		5q35.3		
#121050	CONTRACTURAL ARACHNODACTYLY, CONGENITAL; CCA		5q23.3		
#123790	BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS		10q26.13		
#222448	DONNAI-BARROW SYNDROME		2q31.1		
#605309	MACROCEPHALY/AUTISM SYNDROME		10q23.31		
#142945	HOLOPROSENCEPHALY 3; HPE3		7q36.3		
#157170	HOLOPROSENCEPHALY 2; HPE2		2p21		
#162300	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	MUCOSAL NEUROMA SYNDROME, INCLUDED	10q11.21		
#169100	CHAR SYNDROME; CHAR		6p12.3		
#169400	PELGER-HUET ANOMALY; PHA		1q42.12		
#176450	CURRARINO SYNDROME	SACRAL AGENESIS SYNDROME, INCLUDED	7q36.3		
#180700	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 1; DRS1		3p14.3		
#182212	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS		1p36.33-p36.32		
#201450	ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF; ACADMD		1p31.1		
#203800	ALSTROM SYNDROME; ALMS		2p13.1		
#207800	ARGININEMIA		6q23.2		
#207900	ARGININOSUCCINIC ACIDURIA		7q11.21		
#209900	BARDET-BIEDL SYNDROME 1; BBS1		1p35.2, 3q11.2, 11q13.2		
#215700	CITRULLINEMIA, CLASSIC		9q34.11		
#216340	YUNIS-VARON SYNDROME; YVS		6q21		
#219150	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA; ARCL3A		10q24.1		
#600430	CHROMOSOME 2q37 DELETION SYNDROME		2q37	2:230100000-242193529	
#600721	D-2-HYDROXYGLUTARIC ACIDURIA 1; D2HGA1		2q37.3		
#601224	POTOCKI-SHAFFER SYNDROME		11p11.2	11:43400000-48800000	
#602361	GRACILE BONE DYSPLASIA; GCLEB		11q12.1		
#602501	MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME; MCAP		3q26.32		
#602849	MUENKE SYNDROME; MNKES		4p16.3		
#604369	SALLA DISEASE; SD		6q13		
#604804	MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3		9q33.2		
#226980	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS		2p11.2		
#227810	FANCONI-BICKEL SYNDROME; FBS		3q26.2		
#230350	GALACTOSEMIA III; GALAC3		1p36.11		
#231050	GELEOPHYSIC DYSPLASIA 1; GPHYSD1		9q34.2		
#236250	HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY	MTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	1p36.22		
#237300	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO		2q34		
#241200	BARTTER SYNDROME, TYPE 2, ANTENATAL; BARTS2		11q24.3		
#243310	BARAITSER-WINTER SYNDROME 1; BRWS1		7p22.1		
#249270	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA		1q24.2		
#251000	METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY	METHYLMALONIC ACIDURIA, mut(0) TYPE, INCLUDED	6p12.3		
#251100	METHYLMALONIC ACIDURIA, cblA TYPE		4q31.21		
#251290	PSEUDO-TORCH SYNDROME 1; PTORCH1		5q13.2		
#253260	BIOTINIDASE DEFICIENCY		3p25.1		
#256500	NETHERTON SYNDROME; NETH		5q32		
#256800	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA		1q23.1		
#256810	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6	NAVAJO FAMILIAL NEUROGENIC ARTHROPATHY, INCLUDED	2p23.3		
#258900	OROTIC ACIDURIA	OROTIC ACIDURIA WITHOUT MEGALOBLASTIC ANEMIA, INCLUDED; OAWA, INCLUDED	3q21.2		
#259730	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3		8q21.2		
#259775	RAINE SYNDROME; RNS		7p22.3		
#260400	SHWACHMAN-DIAMOND SYNDROME 1; SDS1		7q11.21		
#267000	PERLMAN SYNDROME; PRLMNS		2q37.1		
#268310	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 1; RRS1	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OF PHALANGES AND METACARPALS/METATARSALS, INCLUDED	9q22.31		
#269000	SC PHOCOMELIA SYNDROME		8p21.1		
#269920	INFANTILE SIALIC ACID STORAGE DISEASE; ISSD		6q13		
#269921	SIALURIA		9p13.3		
#271665	SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE		1q23.3		
#277170	OROFACIODIGITAL SYNDROME VI; OFD6		5p13.2		
#277380	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE; MAHCF		6q13		
#277400	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE, DIGENIC, INCLUDED	1p34.1, 1p34.1		
#277410	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE; MAHCD	HOMOCYSTINURIA, cblD TYPE, VARIANT 1, INCLUDED	2q23.2		
#277590	WEAVER SYNDROME; WVS		7q36.1		
#606407	HYPOTONIA-CYSTINURIA SYNDROME	HOMOZYGOUS 2p21 DELETION SYNDROME, INCLUDED	2p21	2:41500000-47500000	
#606777	GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1	GLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	1p34.2		
#606812	FUMARASE DEFICIENCY; FMRD		1q43		
#607014	HURLER SYNDROME		4p16.3		
#607091	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId; CDG2D		9p21.1		
#607371	DYSTONIA, JUVENILE-ONSET; DJO		7p22.1		
#608022	DIAPHANOSPONDYLODYSOSTOSIS		7p14.3		
#608027	PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3		7q21.11		
#608093	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J		11q23.3		
#608156	NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS		8q22.1	8:92300000-97900000	
#608782	PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY; PDHPD		8q22.1		
#611523	PONTOCEREBELLAR HYPOPLASIA, TYPE 6; PCH6		6q15		
#611553	NOONAN SYNDROME 5; NS5		3p25.2		
#612304	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4		2q14.3		
#612394	BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS		7q22.1		
#612530	CHROMOSOME 1q41-q42 DELETION SYNDROME		1q41-q42	1:214400000-236400000	
#609192	LOEYS-DIETZ SYNDROME 1; LDS1		9q22.33		
#609625	CHROMOSOME 10q26 DELETION SYNDROME		10q26	10:117300000-133797422	
#609757	WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	WBS TRIPLICATION SYNDROME, INCLUDED	7q11.23	7:72700000-77900000	
#610168	LOEYS-DIETZ SYNDROME 2; LDS2		3p24.1		
#610199	DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH		9p24.2		
#610474	CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME; CATSHLS		4p16.3		
#610688	JOUBERT SYNDROME 6; JBTS6		8q22.1		
#610828	HOLOPROSENCEPHALY 7; HPE7		9q22.32		
#611283	ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY; IBDD		11q25		
#613610	CRANIOECTODERMAL DYSPLASIA 2; CED2		2p24.1		
#613730	HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS; HDBSCC		11q25		
#613989	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 4, INCLUDED; DKCB4, INCLUDED	5p15.33		
#614083	FANCONI ANEMIA, COMPLEMENTATION GROUP L; FANCL		2p16.1		
#614732	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES; IMAGE		11p15.4		
#614845	NEPHRONOPHTHISIS 15; NPHP15		11q23.3		
#614863	PEROXISOME BIOGENESIS DISORDER 4B; PBD4B		6p21.1		
#615155	STEEL SYNDROME; STLS		9q32		
#615349	EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2		1p36.33		
#615433	CHROMOSOME 3q13.31 DELETION SYNDROME		3q13.31	3:113700000-117600000	
#615577	IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10		10q24.32		
#615991	BARDET-BIEDL SYNDROME 14; BBS14		8q22.1, 12q21.32		
#615993	BARDET-BIEDL SYNDROME 16; BBS16		1q43-q44		
#616095	MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D		1p13.2		
#616482	ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN		4p16.3		
#616541	SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED		5q14.2		
#616777	SECKEL SYNDROME 9; SCKL9		3p21.31		
#616831	LUSCAN-LUMISH SYNDROME; LLS		3p21.31		
#616854	EVEN-PLUS SYNDROME; EVPLS		5q31.2		
#616902	CHROMOSOME 11p13 DELETION SYNDROME, DISTAL		11p13	11:31000000-36400000	
#617044	SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS; SDDHD		3p21.1		
#617506	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2		2p23.2		
#617598	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3		5p15.33		
#617602	CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM		9q34.12		
#617682	PILAROWSKI-BJORNSSON SYNDROME; PILBOS		5q15-q21		
#617757	JOUBERT SYNDROME 32; JBTS32		10q24.32		
#617761	JOUBERT SYNDROME 31; JBTS31		5q23.2		
#617800	MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19		3q23		
#617904	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 59; DEE59		9q22.33		
#617952	OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18		6q14.1		
#617984	MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22		11q25		
#618008	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65		5q33.3		
#618156	SQUALENE SYNTHASE DEFICIENCY; SQSD		8p23.1		
#618161	JOUBERT SYNDROME 35; JBTS35		10q24.32		
#618162	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK		11q23.3		
#618201	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68		3p22.1		
#618243	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22		2q37.3		
#618278	FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA		10q25.3		
#618284	MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS		11p14.1		
#618342	INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS		7q22.3		
#618357	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15		9q21.13		
#618363	SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS		4q31.22		
#618383	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69		3q12.3		
#618402	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70		3q25.32		
#618440	OCULOSKELETODENTAL SYNDROME; OCSKD		11p15.1		
#618482	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10		5p12		
#618499	NOONAN SYNDROME 11; NS11		3q22.3		
#618523	HYPER-IgE RECURRENT INFECTION SYNDROME 4, AUTOSOMAL RECESSIVE; HIES4		5q11.2		
#618567	MITOCHONDRIAL DNA DEPLETION SYNDROME 17; MTDPS17		7p22.3		
#618596	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 16; EIG16		10q22.3		
#618625	ROTHMUND-THOMSON SYNDROME, TYPE 1; RTS1		2q13		
#618652	NEUROOCULOCARDIOGENITOURINARY SYNDROME; NOCGUS		10p15.3		
#618658	ZIMMERMANN-LABAND SYNDROME 3; ZLS3		1q21.3		
#618725	INTELLECTUAL DEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT SEIZURES; IDDBCS		11p11.2		
#618733	NEUROMUSCULAR OCULOAUDITORY SYNDROME; NMOAS		6p21.33		
#618830	AUTISM, SUSCEPTIBILITY TO, 20; AUTS20		3q26.31		
#618857	DIABETES MELLITUS, PERMANENT NEONATAL 3; PNDM3	DEVELOPMENTAL DELAY, EPILEPSY, AND NEONATAL DIABETES 2, INCLUDED; DEND2, INCLUDED	11p15.1		
#618961	SPONDYLOMETAPHYSEAL DYSPLASIA WITH CORNEAL DYSTROPHY; SMDCD		11q13.1		
#618971	TOLCHIN-LE CAIGNEC SYNDROME; TOLCAS		11p15.2		
#224050	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1		9p24.2		
#609049	PIERSON SYNDROME		3p21.31		
#130070	EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1		5q35.3		
#182230	SEPTOOPTIC DYSPLASIA	PITUITARY HORMONE DEFICIENCY, COMBINED, 5, INCLUDED; CPHD5, INCLUDED	3p14.3		
#204100	LEBER CONGENITAL AMAUROSIS 2; LCA2		1p31.3		
#211750	C SYNDROME		3q13.1-q13.2		
#600901	FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE		6p21.31		
#601110	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D		3q27.1		
#603147	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C		1p31.3		
#230900	GAUCHER DISEASE, TYPE II; GD2		1q22		
#234050	TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4		7p14.1		
#236800	HYDROXYKYNURENINURIA		2q22.2		
#246450	3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD		1p36.11		
#248800	MARINESCO-SJOGREN SYNDROME; MSS		5q31.2		
#250410	RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES; RPSKA		5q12.3		
#256000	LEIGH SYNDROME; LS	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY, INCLUDED	5p15.33		
#257200	NIEMANN-PICK DISEASE, TYPE A	NIEMANN-PICK DISEASE, INTERMEDIATE, PROTRACTED NEUROVISCERAL, INCLUDED	11p15.4		
#257850	OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE		6q22.31		
#605711	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1		2p13.3		
#606054	PROPIONIC ACIDEMIA		3q22.3, 13q32.3		
#606170	GENITOPATELLAR SYNDROME; GTPTS		10q22.2		
#607483	THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2		2q36.3		
#611719	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5		3q23		
#613001	ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL		8p11.23		
#613509	CHROMOSOME 4q21 DELETION SYNDROME		4q21	4:75300000-87100000	
#613550	NEPHRONOPHTHISIS 11; NPHP11		8q22.1		
#609286	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3		10q24.31		
#609924	AMINOACYLASE 1 DEFICIENCY; ACY1D		3p21.2		
#610738	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3		1q21.3		
#610992	PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD		9q21.2		
#613792	CHROMOSOME 3pter-p25 DELETION SYNDROME		3pter-p25		
#614111	PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD		3p14.3		
#614229	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11		1q32.2		
#614462	HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES; HGCLAS		4p14		
#614482	CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND		3q25.31		
#614814	ADAMS-OLIVER SYNDROME 3; AOS3		4p15.2		
#615191	LISSENCEPHALY 5; LIS5		7q31.1		
#615465	HARTSFIELD SYNDROME; HRTFDS		8p11.23		
#616603	CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3		10q24.1		
#616875	CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR		1p36.13		
#225750	AICARDI-GOUTIERES SYNDROME 1; AGS1	AICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	3p21.31		
#613668	MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY		11q21		
#600151	BARDET-BIEDL SYNDROME 3; BBS3		3q11.2		
#249400	MELANOSIS, NEUROCUTANEOUS; NCMS		1p13.2		
#612016	COENZYME Q10 DEFICIENCY, PRIMARY, 4; COQ10D4		1q42.13		
#613174	CHROMOSOME 5p13 DUPLICATION SYNDROME		5p13	5:28900000-42500000	
#609446	PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3		10q22.3		
#610015	GLUTAMINE DEFICIENCY, CONGENITAL		1q25.3		
#610915	OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8		1p34.2		
#611092	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6		6q16.3		
#613658	RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 1; RILDBC1		2q36.1		
#614023	PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD		7p11.2		
#614867	PEROXISOME BIOGENESIS DISORDER 5B; PBD5B		8q21.13		
#615432	SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5		2q36.3		
#615722	BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS		5q15		
#615816	IMMUNODEFICIENCY 23; IMD23		6q14.1		
#615994	BARDET-BIEDL SYNDROME 17; BBS17		3p21.31		
#616421	MYOCLONIC-ATONIC EPILEPSY; MAE		3p25.3		
#616521	MENTAL RETARDATION, AUTOSOMAL DOMINANT 39; MRD39	CHROMOSOME 2p25.3 DELETION SYNDROME, INCLUDED	2p25.3		
#616577	EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS		4q28.1		
#616629	SENIOR-LOKEN SYNDROME 9; SLSN9		2q37.3		
#616794	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28; COXPD28		3p14.1		
#617308	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6		3p14.3		
#617532	INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF		1p36.23		
#617537	RAHMAN SYNDROME; RMNS		6p22.2		
#617744	IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH		2q31.2		
#617788	MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51		11q13.2		
#617796	MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52		1q22		
#617964	LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16		7p21.3		
#618116	BONE MARROW FAILURE SYNDROME 4; BMFS4		1p32.1		
#618709	NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES; NEDBAS		6q27		
#618924	EPISODIC ATAXIA, TYPE 9; EA9		2q24.3		







